Cabergoline reverses cortical hyperexcitability in patients with restless legs syndrome. (Q48433550)

11 February 2018

title

Cabergoline reverses cortical hyperexcitability in patients with restless legs syndrome. (English)

1 reference

11 February 2018

author

Raffaele Nardone

1

1 reference

11 February 2018

author name string

H Ausserer

2

1 reference

11 February 2018

A Bratti

3

1 reference

11 February 2018

M Covi

4

1 reference

11 February 2018

P Lochner

5

1 reference

11 February 2018

R Marth

6

1 reference

11 February 2018

F Tezzon

7

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 October 2006

1 reference

11 February 2018

Acta Neurologica Scandinavica

published in

1 reference

11 February 2018

volume

114

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

244-249

1 reference

11 February 2018

Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Effective cabergoline treatment in idiopathic restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Changes in excitability of motor cortical circuitry in primary restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Motor system excitability in patients with restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Neurophysiological study of corticomotor pathways in restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Motor cortex excitability in restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Transcranial magnetic stimulation and the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

An automated method to determine the transcranial magnetic stimulation-induced contralateral silent period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Corticocortical inhibition in human motor cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

The effect of lorazepam on the motor cortical excitability in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Responses of striatal neurons in the behaving monkey. 3. Effects of iontophoretically applied dopamine on normal responsiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: evidence for the involvement of both dopaminergic and GABAergic components

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Exploring the relationship between Parkinson disease and restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Restless legs syndrome in 218 patients: associated disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

Restless legs syndrome and PD: a review of the evidence for a possible association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00669.X

10.1111/J.1600-0404.2006.00669.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

16942543

1 reference

11 February 2018